Concepedia

Karl L. Banta

KL

9

Publications

1.5K

Citations

9

H-Index

2011

Active since

Affiliations

University of California, Berkeley(Current)

Gene Therapy Laboratory

Genesys (United States)

UCSF Helen Diller Family Comprehensive Cancer Center

University of California, San Francisco

Karl L. Banta is an author at University of California, Berkeley specializing in cancer research, medicine, and lung cancer.

ORCID

Top concepts

Publications per year

2011–2024

9

Publications

9

Peripheral T cell expansion predicts tumour infiltration and clinical response

Thomas D. Wu, Shravan Madireddi, Patrícia E. de Almeida et al. · Nature · 2020 · 770 citations

, , +8

Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses

Karl L. Banta, Xiaozheng Xu, Avantika S. Chitre et al. · Immunity · 2022 · 324 citations · Full text

Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells

Xiangnan Guan, Ruozhen Hu, Yoonha Choi et al. · Nature · 2024 · 102 citations · Full text

CD96 functions as a co‐stimulatory receptor to enhance CD8 <sup>+</sup> T cell activation and effector responses

Eugene Y. Chiang, Patricia E. de Almeida, Denise E. de Almeida Nagata et al. · European Journal of Immunology · 2020 · 94 citations · Full text

Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis

Minh D. To, Reyno Del Rosario, Peter M.K. Westcott et al. · Oncogene · 2012 · 85 citations · Full text

, , +9

Rows per page

1–5 of 9